sb 200646 has been researched along with kynurenic acid in 1 studies
| Studies (sb 200646) | Trials (sb 200646) | Recent Studies (post-2010) (sb 200646) | Studies (kynurenic acid) | Trials (kynurenic acid) | Recent Studies (post-2010) (kynurenic acid) |
|---|---|---|---|---|---|
| 24 | 0 | 5 | 2,611 | 28 | 750 |
| Protein | Taxonomy | sb 200646 (IC50) | kynurenic acid (IC50) |
|---|---|---|---|
| Neuronal acetylcholine receptor subunit alpha-7 | Homo sapiens (human) | 7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brotchie, JM; Fox, SH; Moser, B | 1 |
1 other study(ies) available for sb 200646 and kynurenic acid
| Article | Year |
|---|---|
Behavioral effects of 5-HT2C receptor antagonism in the substantia nigra zona reticulata of the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Dopamine Agonists; Excitatory Amino Acid Antagonists; Indoles; Kynurenic Acid; Locomotion; Male; Microinjections; Oxidopamine; Parkinson Disease, Secondary; Pyridines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Serotonin Antagonists; Substantia Nigra; Sympatholytics; Urea | 1998 |